132 related articles for article (PubMed ID: 36379241)
1. Drug checking services as a surveillance tool for clinical laboratories: Examining trends in the unregulated fentanyl supply.
Delaney SR; Konforte D; Stefan C; Palaty J; Sun D; McDonald K; Thompson H; Werb D; Beriault DR
Clin Biochem; 2023 Jan; 111():11-16. PubMed ID: 36379241
[TBL] [Abstract][Full Text] [Related]
2. Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019-April 2020.
Scarfone KM; Maghsoudi N; McDonald K; Stefan C; Beriault DR; Wong E; Evert M; Hopkins S; Leslie P; Watson TM; Werb D;
Harm Reduct J; 2022 Jan; 19(1):3. PubMed ID: 35012557
[TBL] [Abstract][Full Text] [Related]
3. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
Maghsoudi N; McDonald K; Stefan C; Beriault DR; Mason K; Barnaby L; Altenberg J; MacDonald RD; Caldwell J; Nisenbaum R; Leece P; Watson TM; Tupper KW; Kufner L; Scheim AI; Werb D;
Harm Reduct J; 2020 Jan; 17(1):9. PubMed ID: 32204713
[TBL] [Abstract][Full Text] [Related]
4. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
Laing MK; Ti L; Marmel A; Tobias S; Shapiro AM; Laing R; Lysyshyn M; Socías ME
Int J Drug Policy; 2021 Jul; 93():103169. PubMed ID: 33627302
[TBL] [Abstract][Full Text] [Related]
5. Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies.
Crepeault H; Socias ME; Tobias S; Lysyshyn M; Custance A; Shapiro A; Ti L
Drug Alcohol Rev; 2023 Mar; 42(3):538-543. PubMed ID: 36423900
[TBL] [Abstract][Full Text] [Related]
6. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
[TBL] [Abstract][Full Text] [Related]
7. Emerging synthetic cannabinoids detected by a drug checking service in Toronto, Canada.
Scarfone KM; Maghsoudi N; McDonald K; Thompson H; Stefan C; Beriault DR; Werb D; Bowles JM
Clin Toxicol (Phila); 2022 Aug; 60(8):979-984. PubMed ID: 35546568
[TBL] [Abstract][Full Text] [Related]
8. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E
Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island.
Collins AB; Wightman RS; Macon EC; Guan Y; Shihipar A; Krieger M; Elmaleh R; Smith MC; Morales A; Badea A
Int J Drug Policy; 2023 Aug; 118():104118. PubMed ID: 37422985
[TBL] [Abstract][Full Text] [Related]
10. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications.
Bowles JM; McDonald K; Maghsoudi N; Thompson H; Stefan C; Beriault DR; Delaney S; Wong E; Werb D
Harm Reduct J; 2021 Oct; 18(1):104. PubMed ID: 34645480
[TBL] [Abstract][Full Text] [Related]
11. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
Borden SA; Saatchi A; Vandergrift GW; Palaty J; Lysyshyn M; Gill CG
Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
[TBL] [Abstract][Full Text] [Related]
12. A survey of North American drug checking services operating in 2022.
Park JN; Tardif J; Thompson E; Rosen JG; Lira JAS; Green TC
Int J Drug Policy; 2023 Nov; 121():104206. PubMed ID: 37797571
[TBL] [Abstract][Full Text] [Related]
13. Drug checking use and interest among people who inject drugs in Toronto, Canada.
Rammohan I; Bouck Z; Fusigboye S; Bowles J; McDonald K; Maghsoudi N; Scheim A; Werb D
Int J Drug Policy; 2022 Sep; 107():103781. PubMed ID: 35803177
[TBL] [Abstract][Full Text] [Related]
14. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
Klaire S; Janssen RM; Olson K; Bridgeman J; Korol EE; Chu T; Ghafari C; Sabeti S; Buxton JA; Lysyshyn M
Int J Drug Policy; 2022 Aug; 106():103741. PubMed ID: 35671687
[TBL] [Abstract][Full Text] [Related]
15. Variability in the unregulated opioid market in the context of extreme rates of overdose.
Larnder A; Saatchi A; Borden SA; Moa B; Gill CG; Wallace B; Hore D
Drug Alcohol Depend; 2022 Jun; 235():109427. PubMed ID: 35405459
[TBL] [Abstract][Full Text] [Related]
16. Fentanyl analog positivity among near-real-time urine drug test results in patients seeking health care.
Stanton JD; Whitley P; LaRue L; Bundy WL; Dawson E; Huskey A
Drug Alcohol Depend; 2020 Dec; 217():108264. PubMed ID: 32980789
[TBL] [Abstract][Full Text] [Related]
17. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
18. The North American opioid epidemic: opportunities and challenges for clinical laboratories.
Delaney SR; Tacker DH; Snozek CLH
Crit Rev Clin Lab Sci; 2022 Aug; 59(5):309-331. PubMed ID: 35166639
[TBL] [Abstract][Full Text] [Related]
19. Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies.
Bhuiyan I; Tobias S; Ti L
Am J Drug Alcohol Abuse; 2023 Nov; 49(6):685-690. PubMed ID: 37506334
[TBL] [Abstract][Full Text] [Related]
20. Changes in the unregulated opioid drug supply during income assistance payment weeks in Vancouver, Canada: An exploratory analysis.
Beaulac M; Richardson L; Tobias S; Lysyshyn M; Grant C; Ti L
Int J Drug Policy; 2022 Jul; 105():103707. PubMed ID: 35504093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
